Goldman SachsGSCOMMENTOct 19, 2016Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
A traditional investment bank, arguably one of the best if not the best. Their business has completely downscaled over the years, with a whole series of initiatives out of the US, to reduce risks. Their revenue, for a large part, comes through capital markets and transaction business, as well as a stable asset management business. A great company, however a very hard stock to necessarily own, because you have all the capital markets uncertainty, pressure on the banks. They are probably the poster boy, whether right or wrong, for public angst. This is something you have to trade a little, rather than being a long-term hold.